Opening https://www.businesswire.com/news/home/20240109217220/en/Chiesi-Group-and-Oak-Hill-Bio-announce-License-and-Development-Agreement-to-develop-manufacture-and-commercialize-OHB-607-a-potentially-transformative-neonatal-therapy